Regular check-ins and education about nutrition and activity make a measurable difference in long-term results
Longevity comes into play when youre disease-free, Patel said
Discovery of the once-weekly GLP-1 analog semaglutide
In a retrospective study, 36 104 (10.9%) of 954 patients presenting to a tertiary diabetic clinic developed treatment-induced diabetic neuropathy with symptoms occurring within 8 weeks of rapid glycemic control
The REWIND trial was noteworthy as, from its total of 9,901 participants, the majority (68.5%) had CV risk factors only at baseline and fewer than one-third (31.5%) had established CVD
Therefore, individuals experienced greater increases in heart rate, with more pronounced subjective-type effects of the drug and psychomotor and cognitive impairments